myTomorrows provides physicians and patients that are excluded from clinical trials access to innovative drugs in development. We focus on disease areas with high unmet needs; oncology, neurology, psychiatry and rare diseases. myTomorrows identifies innovative drugs, informs physicians and patients and facilitates requests for access to these drugs in development.
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as myTomorrows? We’re happy to assist you with our Startup Sourcing service.
